Endocyte (ECYT) Tops Q3 EPS by 3c

Endocyte (NASDAQ: ECYT) reported Q3 EPS of ($0.24), $0.03 better than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Endocyte (ECYT) click here.

You May Also Be Interested In

• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• Stifel Previews Levi Strauss & Co. (LEVI) Earnings: 'Expecting Upside Passed Through to FY26E Guidance'
• JPMorgan Reinstates Adidas AG (ADS:GR) (ADDYY) at Overweight